Roel J P, Hildebrant C L, Grimm R H
Berman Center for Outcomes and Clinical Research, HCMC Department of Medicine #865B, 701 Park Avenue, Minneapolis, MN 55415, USA.
Curr Hypertens Rep. 2001 Dec;3(6):466-72. doi: 10.1007/s11906-001-0008-8.
Therapeutic treatment of hypertension has been achieved successfully with both pharmacologic and nonpharmacologic interventions. Clinical trials have shown that various approaches to treatment result in different levels of blood pressure reduction as well as varying effects on quality of life. Standardizing the approach to measuring quality of life would be beneficial to the assessment of treatment outcomes in hypertension trials. This article reviews some of the strengths and weaknesses of both pharmacologic and nonpharmacologic treatments of hypertension, with special emphasis placed on effects of quality of life.
